Medicine is still largely a cottage industry. Most doctors work in small practices where records are kept on paper. But now technology is starting to reshape this industry. The spread of electronic patient records, heavily promoted by government subsidies, will energize companies in such diverse fields as cloud computing, mobile phones, and even artificial intelligence.
Many of the companies on the cutting edge of electronic medicine are raw startups or privately held, and turbulent market conditions are likely to discourage most from seeking an initial public offering anytime soon. But Technology Review assembled a list of public companies that investors could consider. Here are nine, along with the issues that stock bulls and bears might see in each.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.